In her place, the DIA appointed William Brassington as acting executive director on an interim basis. The statement didn’t disclose why McGoldrick left.
According to the statement from Marie Dray, president DIA’s Board of Directors, Brassington has a long history of service with DIA. Since August 2003, he has been chief financial officer, and he served as acting executive director before McGoldrick was hired.
“Through these roles, William has gained the respect and confidence of the DIA staff, the Board of Directors and association members, enabling him to ensure seamless operations during this transition period,” Dray said in the statement.
The 18,000-member association provides a global exchange of drug information, and conducts education and training programs. In June, DIA hosted its most successful annual meeting in Boston with almost 9,000 members and speakers in attendance.